Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8926976 Modulators

Patent 8926976 was granted and assigned to XOMA on January, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

XOMA

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8926976

Patent Inventor Names

Susan R. Watson0

John Corbin0

Mark Leslie White0

Vinay Bhaskar0

Date of Patent

January 6, 2015

Patent Application Number

12890598

Date Filed

September 24, 2010

Patent Citations Received

‌

US Patent 11771842 Syringes, syringe containers, kits and methods of use

‌

US Patent 11787876 Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof

‌

US Patent 11685775 Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody

Patent Primary Examiner

‌

Zachary Skelding

Patent abstract

Antibodies that modulate insulin receptor signaling are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8926976 Modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API